ArticleFrontiers in cellular and infection microbiology2025
Phenotypic characterization of two neuroinvasive Toscana virus strains clinically associated with self-limited and persistent infections in human neural cells and brain organoids.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Clinical review of Toscana virus: a Mediterranean Neuroinvasive Phlebovirus.Frontiers in epidemiology · 2026Review
- Hidden in Plain Sight: Alphavirus Persistence and Its Potential for Driving Chronic Pathogenesis.Viruses · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Toscana virus (TOSV), a sandfly-borne phlebovirus, is a frequent cause of viral meningitis and meningoencephalitis in Mediterranean countries during summer months. Clinical outcomes vary from self-limited disease to prolonged persistent infection lasting over 3 months, but the mechanisms underlying these differences remain unclear. In this study, we compared the pathobiological features of two clinical TOSV strains, SI-1812 (associated with self-limited disease) and INMI (associated with persistent infection), using human neural models. Methods: Three human neural systems, DBTRG.05MG glioblastoma cells, embryonic stem cell-derived neurons, and human brain organoids (hBOs), were infected with the two TOSV strains. Viral replication, cytopathic effect, innate immune response, and viral protein expression were assessed. Furthermore, whole-genome sequencing was performed to identify strain-specific differences. Results: The INMI strain showed reduced replication and cytopathic effect compared to SI-1812, supporting persistent infection in hBOs for up to 21 days. SI-1812 infection triggered a strong interferon-β response even at early stages of infection and low viral titers, whereas INMI induced a modest innate immune response in the early stages of infection, likely supporting its persistence in hBOs. The timing of viral NSs protein expression differred between the two viral strains suggesting distinct mechanisms in RIG-I activation and inflammatory response modulation. Conclusions: Distinct host-pathogen interactions underlie the divergent clinical courses of TOSV strains. The findings provide insights into mechanisms of viral persistence in the human brain and may guide future therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.